PUBLISHER: The Business Research Company | PRODUCT CODE: 1939274
PUBLISHER: The Business Research Company | PRODUCT CODE: 1939274
Artificial organs are devices designed to be implanted or integrated into the human body, serving the purpose of replacing, duplicating, or augmenting specific functions to enable patients to return to normal life.
The primary types of artificial organs encompass artificial hearts, artificial kidneys, artificial livers, artificial pancreas, and others. For instance, an artificial heart is an implanted pump that takes over the function of damaged heart ventricles and valves. It is operated by an external mechanism called a driver. These devices are made from materials such as silicone, plastic, steel, and biomaterials, and can be fixed through implantable or external means. Various end-users benefit from artificial organs, including hospitals, ambulatory surgical centers, laboratories, diagnostic centers, research institutions, and academic institutes.
Tariffs are impacting the artificial organ market by increasing costs of imported biomaterials, precision manufacturing equipment, electronic control systems, and implantable components. Hospitals and research institutions in North America and Europe are most affected due to reliance on imported high-grade materials, while Asia-Pacific faces higher production costs for export-oriented devices. These tariffs are increasing device prices and slowing adoption rates. However, they are also driving domestic production, localized biomaterial sourcing, and regional innovation in artificial organ development.
The artificial organ market research report is one of a series of new reports from The Business Research Company that provides artificial organ market statistics, including artificial organ industry global market size, regional shares, competitors with a artificial organ market share, detailed artificial organ market segments, market trends and opportunities, and any further data you may need to thrive in the artificial organ industry. This artificial organ market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The artificial organ market size has grown rapidly in recent years. It will grow from $25.73 billion in 2025 to $28.36 billion in 2026 at a compound annual growth rate (CAGR) of 10.2%. The growth in the historic period can be attributed to increasing organ failure cases, shortage of donor organs, advancements in biomedical engineering, growth of dialysis and cardiac support therapies, expanding transplant waiting lists.
The artificial organ market size is expected to see strong growth in the next few years. It will grow to $41.12 billion in 2030 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to increasing investments in bioengineered organs, rising adoption of personalized implant solutions, expansion of artificial organ research funding, technological progress in regenerative medicine, growing acceptance of long-term implantable devices. Major trends in the forecast period include increasing adoption of implantable artificial organs, rising use of advanced biomaterials, growing integration of smart and sensor-enabled organs, expansion of minimally invasive implantation techniques, enhanced focus on long-term biocompatibility.
The growing need for organ transplants is anticipated to support the expansion of the artificial organ market in the coming years. Organ transplantation refers to a medical procedure in which an organ or tissue is taken from a donor and surgically implanted into a recipient to replace a damaged or failing organ. Artificial organ technologies support transplantation by offering temporary or permanent organ substitutes, reducing reliance on donor availability and enhancing patient survival outcomes. For example, in July 2025, according to a report released by NHS Blood and Transplant, a United Kingdom-based government organization, as of March 2025, 8,096 patients, including 276 children, were registered on the active transplant waiting list, representing the highest level ever recorded. In addition, nearly 3,883 individuals were temporarily suspended, resulting in almost 12,000 people facing ongoing uncertainty regarding access to life-saving transplants. Consequently, the rising demand for organ transplants is contributing to the growth of the artificial organ market.
Leading companies operating in the artificial organ market are increasingly prioritizing innovative offerings, such as artificial intelligence-enabled pathology solutions, to strengthen revenue generation. AI-powered pathology solutions are reshaping the pathology landscape by equipping pathologists with advanced tools that enhance diagnostic precision, operational efficiency, and patient outcomes. For instance, in September 2023, Aiosyn, a Netherlands-based medical software company specializing in AI-driven pathology solutions, introduced an AI kidney suite. This solution is designed to objectively quantify kidney lesion scores, improve result consistency, and accelerate drug discovery through AI-enabled computational pathology methods. The platform enables research institutions and biopharmaceutical companies to examine kidney structures and measure lesions affecting renal health by leveraging advanced deep-learning technology.
In March 2024, Nippon Express Holdings, Inc., a Japan-based logistics services provider, acquired a stake in Instalimb, Inc. for an undisclosed amount. This acquisition is intended to enhance Nippon's corporate value while tackling social issues. The investment will support Instalimb's logistics and business growth in Asian markets and potentially in emerging regions of Africa in the future. Instalimb, Inc. is a Japan-based start-up that specializes in 3D-printed prosthetics.
Major companies operating in the artificial organ market are Medtronic plc, Abbott Laboratories Inc., SynCardia Systems LLC, Berlin Heart GmbH, ABIOMED Inc., Carmat SA, Jarvik Heart Inc., Baxter International Inc., B. Braun Melsungen AG, Terumo Corporation, Organovo Holdings Inc., Satellite Bio, HeartWare plc, Boston Scientific Services Private Limited, Edwards Lifesciences India Pvt. Ltd., LIVANOVA plc, NeuroPace Inc., Cochlear Limited, Cyberonics Inc., Demant A/S, LifeNet Health Inc., Vivani Medical Inc., Tissium SAS
North America was the largest region in the artificial organ market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the artificial organ market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the artificial organ market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The artificial organ market consists of sales of orthopedic devices, neuroprostheses and neurological support, urological support, visual support systems, blood cell and tissue replacement systems, mechanical organs made of inanimate polymers, and biomechanical organs made of partially living cells and inanimate polymers. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Artificial Organ Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses artificial organ market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for artificial organ ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The artificial organ market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.